How should a percutaneous transhepatic biliary drainage (PTBD) catheter be managed, including sterile maintenance, flushing protocol, dressing changes, infection monitoring, antibiotic therapy, imaging follow‑up, and criteria for catheter removal?

PTBD Management

For percutaneous transhepatic biliary drainage (PTBD) management, implement sterile dressing changes every 2 days for gauze or every 7 days for transparent dressings, flush the catheter regularly to maintain patency, initiate broad-spectrum antibiotics (piperacillin/tazobactam or carbapenems) for 4-7 days when source control is adequate, and remove the catheter once clinical resolution is achieved and imaging confirms resolution of the underlying pathology.

Sterile Maintenance and Dressing Protocol

Dressing changes must follow strict sterile technique. Use either sterile gauze or sterile transparent semi-permeable dressings to cover the catheter exit site 1.

• Replace gauze dressings every 2 days 1
• Replace transparent dressings every 7 days 1
• Change dressings immediately if they become damp, loosened, or visibly soiled 1
• If the site is bleeding, oozing, or the patient is diaphoretic, use gauze dressing until resolved 1

Skin preparation: Use 0.5% chlorhexidine preparation with alcohol for dressing changes. If chlorhexidine is contraindicated, use tincture of iodine, iodophor, or 70% alcohol as alternatives 1. Allow antiseptic to dry completely before applying new dressing 1.

Do not use topical antibiotic ointments or creams at the insertion site, as these promote fungal infections and antimicrobial resistance 1.

Hand hygiene is mandatory before and after any catheter manipulation, even when wearing gloves 2.

Flushing Protocol

Regular flushing is essential to prevent catheter occlusion, which occurs in approximately 15% of cases requiring premature exchange 3. While specific flushing intervals are not standardized in guidelines, clinical practice typically involves:

• Daily flushing with sterile saline
• Immediate flushing if occlusion is suspected during routine care
• Monitoring for resistance during flushing, which may indicate catheter dysfunction

Catheter occlusion is a common problem requiring premature exchange in 15% of cases 3. Consider reducing exchange intervals from 3 to 2 months if recurrent occlusion occurs, as this can decrease premature exchanges by 26% 3.

Infection Monitoring

Monitor the catheter site visually when changing dressings or by palpation through intact dressings on a regular basis 1.

Signs requiring immediate attention:

• Fever (>38°C)
• Erythema or purulence at exit site
• Pain, heat, or tenderness at the catheter site
• Bile leakage alongside the drain (occurs in 33% of premature exchanges) 3
• Systemic signs of sepsis

Late cholangitis episodes occur in approximately 14.5% of patients with long-term PTBD 4. Patients with ongoing signs of infection beyond 7 days of antibiotic treatment warrant diagnostic investigation 5.

Antibiotic Therapy

Initiate antibiotics immediately (within 1 hour) for biliary infection or sepsis 6.

For Immunocompetent, Non-Critically Ill Patients with Adequate Source Control:

• Piperacillin/tazobactam 4g/0.5g q6h or 16g/2g continuous infusion 5
• Alternative: Amoxicillin/clavulanate 2g/0.2g q8h 5
• Duration: 4 days if source control is adequate 5

For Critically Ill or Immunocompromised Patients:

• Piperacillin/tazobactam 6g/75g loading dose, then 4g/0.5g q6h or continuous infusion 5
• Duration: Up to 7 days based on clinical conditions and inflammatory markers 5

For Inadequate/Delayed Source Control or High Risk of ESBL-Producing Organisms:

• Ertapenem 1g q24h 5
• Alternative: Eravacycline 1mg/kg q12h 5

For Septic Shock:

• Meropenem 1g q6h by extended or continuous infusion 5
• Alternatives: Doripenem 500mg q8h, Imipenem/cilastatin 500mg q6h, or Eravacycline 1mg/kg q12h 5

For patients with previous biliary stenting, PTBD, or history of cholangitis: Use broad-spectrum antibiotics (4th-generation cephalosporins or carbapenems) with adjustments based on culture results 6.

Imaging Follow-Up

Initial imaging modalities for biliary pathology assessment:

• Ultrasound for basic evaluation
• CT with IV contrast for detailed assessment
• MRI/MRCP for exact visualization and classification
• ERCP when endoscopic intervention is planned 5, 6

Follow-up imaging should be performed:

• When clinical improvement plateaus or worsens
• Before catheter removal to confirm resolution of obstruction or leak
• If persistent fever or signs of infection occur despite treatment
• To evaluate for complications (biloma, abscess, persistent leak)

Catheter Removal Criteria

Remove the PTBD catheter when:

• Clinical resolution is achieved (no fever, normalized inflammatory markers)
• Imaging confirms resolution of biliary obstruction or leak
• Bilirubin levels normalize or significantly decrease (>10 mg/dL reduction) 4
• No bile leakage is present
• The underlying pathology is definitively treated

Do not routinely replace catheters solely for infection prevention 2. However, scheduled exchanges every 3 months are recommended for long-term drainage to prevent catheter-related complications 3.

Promptly remove any catheter that is no longer essential 1.

Common Pitfalls and Complications

Major complications occur in approximately 4% of cases 7, including:

• Bleeding from liver parenchyma or intercostal vessels (2.5% overall, higher with coagulopathy) 8, 7
• Bile peritonitis
• Catheter dislocation (30% of premature exchanges) 3
• Cholangitis (14.5% late complication rate) 4

Catheter-related problems requiring premature exchange occur in 47% of cases 3:

• Bile leakage alongside drain (33%)
• Disconnection or complete dislocation (30%)
• Occlusion (15%)
• Clinical fever/dysfunction (19%)

Risk factors for clinical failure:

• Age >65 years 7
• Left-sided drainage 7
• Coagulopathy (contraindication for PTBD) 8
• Moderate to massive ascites (relative contraindication) 8

Prevention strategies:

• Maintain strict sterile technique during all manipulations
• Regular flushing to prevent occlusion
• Secure catheter properly to prevent dislocation
• Monitor for early signs of infection or dysfunction
• Consider reducing exchange intervals to 2 months if recurrent problems occur 3